1. 156 ANALYSIS OF A TARGETED RECEPTOR TYROSINE KINASE INHIBITOR IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA. (1st January 2005) Authors: Menzel, L. P.; Shankar, D. B.; Shah, N. P.; Hummerickhouse, R.; Hagey, A.; Sakamoto, K. M.; Moore, T. B. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria. Issue 16 (9th December 2016) Authors: Wan, L. Y. M.; Chen, Z. J.; Shah, N. P.; El-Nezami, H. Journal: Critical reviews in food science and nutrition Issue: Volume 56:Issue 16(2016) Page Start: 2628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE. (23rd June 2022) Authors: Shah, N. P.; García-Gutiérrez, V.; Jiménez-Velasco, A.; Saussele, S.; Rea, D.; Mahon, F.-X.; Levy, M. Y.; Gómez-Casares, M. T.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗